Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Avid Bioservices Inc (CDMO)
Avid Bioservices Inc (CDMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 939,456
  • Shares Outstanding, K 62,547
  • Annual Sales, $ 119,600 K
  • Annual Income, $ 127,670 K
  • 60-Month Beta 1.82
  • Price/Sales 7.52
  • Price/Cash Flow 41.69
  • Price/Book 5.07
Trade CDMO with:

Options Overview Details

View History
  • Implied Volatility 59.34% ( -0.07%)
  • Historical Volatility 51.81%
  • IV Percentile 26%
  • IV Rank 18.39%
  • IV High 129.65% on 11/15/22
  • IV Low 43.50% on 05/09/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 68
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 1,740
  • Open Int (30-Day) 1,422

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/23
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year 0.04
  • Growth Rate Est. (year over year) -150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.21 +8.37%
on 05/18/23
18.86 -18.35%
on 05/05/23
-2.65 (-14.68%)
since 04/28/23
3-Month
13.48 +14.24%
on 03/10/23
21.05 -26.84%
on 04/13/23
-1.06 (-6.44%)
since 02/28/23
52-Week
11.34 +35.80%
on 12/07/22
21.05 -26.84%
on 04/13/23
+1.63 (+11.84%)
since 05/27/22

Most Recent Stories

More News
Is Your Portfolio Healthy? Don't Touch This Stock With a Ten-Foot Pole!

Amidst lingering economic uncertainties, pharma contract development company Avid Bioservices (CDMO) has been flashing red flags with deteriorating financial results in the last reported quarter and bleak...

CDMO : 15.42 (+2.66%)
NVO : 160.75 (+0.59%)
NVS : 96.25 (-0.31%)
TAK : 15.86 (-1.37%)
Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3

Avid Bioservices Inc. (NASDAQ: CDMO) is a contract development and manufacturing organization (CDMO) that specializes in producing monoclonal antibodies,

REGN : 734.95 (+0.87%)
CDMO : 15.42 (+2.66%)
AMGN : 220.73 (+1.01%)
BIIB : 296.19 (-0.84%)
Why Avid Bioservices Stock Is Surging Today

The bio-manufacturer's ongoing expansion efforts are a hit with investors.

CDMO : 15.42 (+2.66%)
Avid Bioservices (CDMO) Q3 Earnings and Revenues Top Estimates

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 275% and 5.61%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

CDMO : 15.42 (+2.66%)
HOOK : 1.3100 (-5.76%)
Steer Clear Of These 4 Toxic Stocks to Avoid Losses

Correctly spotting overpriced stocks and shunning them at the right time may avoid portfolio bleeding. ILMN, LTRX, BSY and CDMO are a few such toxic stocks.

ILMN : 196.80 (+1.18%)
LTRX : 4.41 (-16.00%)
CDMO : 15.42 (+2.66%)
BSY : 48.81 (+0.66%)
Lumos Pharma (LUMO) Reports Q4 Loss, Tops Revenue Estimates

Lumos (LUMO) delivered earnings and revenue surprises of -3.16% and 48.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LUMO : 3.67 (-7.32%)
CDMO : 15.42 (+2.66%)
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Lags Revenue Estimates

Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 24.32% and 1.17%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

ADPT : 6.99 (-0.86%)
CDMO : 15.42 (+2.66%)
Avid Bioservices (CDMO) Reports Q2 Loss, Tops Revenue Estimates

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 0% and 12.12%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?

CDMO : 15.42 (+2.66%)
LFCR : 8.21 (+2.50%)
Kamada (KMDA) Q3 Earnings and Revenues Top Estimates

Kamada (KMDA) delivered earnings and revenue surprises of 433.33% and 8.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

KMDA : 4.86 (-2.41%)
CDMO : 15.42 (+2.66%)
Evogene (EVGN) Reports Q3 Loss, Tops Revenue Estimates

Evogene (EVGN) delivered earnings and revenue surprises of 20% and 79.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

EVGN : 0.6101 (-4.67%)
CDMO : 15.42 (+2.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing...

See More

Key Turning Points

3rd Resistance Point 15.98
2nd Resistance Point 15.70
1st Resistance Point 15.36
Last Price 15.42
1st Support Level 14.74
2nd Support Level 14.46
3rd Support Level 14.12

See More

52-Week High 21.05
Fibonacci 61.8% 17.34
Fibonacci 50% 16.19
Last Price 15.42
Fibonacci 38.2% 15.05
52-Week Low 11.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar